Effect of chronic proton pump inhibitor therapy on complete blood count parameters and selected trace elements - pilot study.
Proton pump inhibitors (PPIs) are widely prescribed for several gastrointestinal conditions, often as chronic therapy. The effects of long-term PPI use have not been fully elucidated. We aimed to determine the association between chronic PPI use and complete blood count parameters, particularly red blood cell (RBC) count, white blood cell (WBC) count, and hemoglobin concentrations, as well as serum levels of selected micronutrients such as selenium (Se), iron (Fe), copper (Cu), and zinc (Zn). We enrolled 37 patients on chronic PPI therapy (mean [SD] age, 57.1 [15.4] years) and 30 healthy controls (mean [SD] age, 39.3 [11.8] years). In each group, complete blood count, serum Fe levels were performed, and serum Cu, Zn, and Se levels were measured using atomic absorption spectrometry. RBC and WBC counts were lower in the PPI group compared with controls (mean [SD], 4.24 [0.55] 106/µl vs 4.7 [0.4] 106/µl, P <0.001 and 6.13 [1.44] 103/µl vs 7.3 [1.28] 103/µl, P <0.001, respectively]. Hemoglobin and serum Fe concentrations were also lower in the PPI group (mean [SD], 12.5 [1.8] g/dl vs 14.3 [0.8] g/dl; P <0.001 and 16.3 [5.4] µmol/l vs 23.4 [2.7] µmol/l, P <0.001). Serum Zn and Cu concentrations were significantly higher in PPI users than in controls. Chronic PPI therapy may reduce RBC and WBC counts as well as hemoglobin levels, leading to iron deficiency. It may also affect the concentrations of some micronutrients, although the underlying mechanism of this association is not fully clear.